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Abstract A first seizure is a life-changing event with
physical and psychological consequences. We aimed to
assess the role of early comprehensive patient care after a
first unprovoked seizure to improve diagnostic accuracy
and follow-up adherence. From April 2011 to March 2012,
patients presenting a first unprovoked epileptic seizure
received standard patient care (SPC), i.e., a consultation in
the ED, an EEG and a CT scan. The patients were notified
of the follow-ups. We compared this protocol to subse-
quently acquired ‘‘early comprehensive patient care’’
(ECPC), which included a consultation by an epileptologist
in the emergency department (ED), a routine or long-term
monitoring electroencephalogram (LTM-EEG), magnetic
resonance imaging and three follow-up consultations
(3 weeks, 3 months, 12 months). 183 patients were inclu-
ded (113 ECPC, 70 SPC). LTM-EEG and MRI were per-
formed in 51 and 85 %, respectively, of the patients in the
ECPC group vs in 7 and 52 % of the patients in the SPC
group (p\ 0.001). A final diagnosis was obtained in 64 vs
43 % of the patients in the ECPC vs SPC group (p\ 0.01).
Patient attendance at 3-month was 84 % in the ECPC
group vs 44 % in the SPC group (p\ 0.001). At 12-month
follow-up, the delay until the first recurrence was longer in
the ECPC group (p = 0.008). An early epileptologist-dri-
ven protocol is associated with clinical benefit in terms of
diagnostic accuracy, follow-up adherence and recurrence.
This study highlights the need for epilepsy experts in the
early assessment of a first epileptic seizure, starting already
in the ED.
Keywords Follow-up  Brain imaging  EEG  Seizure
recurrence  Cost analysis
Introduction
Epilepsy is one of the most frequently occurring neuro-
logical diseases, affecting between 0.5 and 1 % of the
population [2]. The current definition of epilepsy requires
at least one unprovoked seizure together with electroen-
cephalogram (EEG) and brain imaging results in support of
an enduring predisposition for subsequent seizures [7, 10].
In most developed countries, people who present with
seizures are admitted to the emergency department (ED)
and are evaluated by a physician or neurologist but not
necessarily by an epilepsy expert. Depending on local
resources, the patient is then referred to his general prac-
titioner (GP) or directly to an outpatient clinic. In some
countries, patients are encouraged to make an appointment
at a ‘‘first seizure clinic’’ managed by epilepsy experts
within the next days or weeks. However, in all scenarios, a
certain amount of time elapses before the results of further
diagnostic tests conducted outside the ED are obtained; this
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delay increases the risk that a patient will not return for
follow-up. In our experience, approximately 30 % of all
patients do not return for follow-up, although to the best of
our knowledge, no study has been conducted.
Several medical organizations [e.g., the Scottish Inter-
collegiate Guidelines Network (SIGN) [4], the American
Academy of Neurology [12, 13], the National Institute for
Health and Care Excellence (NICE) in the UK and the
German Society of Neurology [6] (GSN)] have established
guidelines and provide recommendations on which exams
should be performed and when. SIGN [16] and NICE [22]
concur that an epilepsy diagnosis should be made by an
expert within the 2 weeks following the event and agree
that a routine EEG should be conducted as soon as possi-
ble. SIGN and GSN postulate that magnetic resonance
imaging (MRI) is the exam of choice in patients with
epilepsy and on the other hand, NICE recommends sleep
electroencephalography over repeated wake EEGs, pro-
vided that the first routine recording is negative. Thus,
there is no consensus regarding the specific type and timing
of advanced diagnostic tests if first-line exams fail to show
unequivocal epileptogenic abnormalities.
In the present prospective single-center study, we
compared the yield of early comprehensive patient care
(ECPC) with standard patient care (SPC) in the setting of a
first unprovoked seizure. The ECPC included three con-
sultations by epilepsy experts and all further investigations
needed over a short period (see below). We hypothesized
the following: (a) ECPC will more often and more rapidly
lead to an accurate diagnosis than SPC; (b) ECPC will
yield higher adherence to follow-up and treatment moni-
toring; and (c) Despite higher initial costs related to the
comprehensive work-up, ECPC will show long-term cost
efficiency due to reduced emergency admissions.
Methods
Patients
Between April 2011 and June 2013, we prospectively
included all patients admitted to the adult ED (older than
15 years of age) of the University Hospitals of Geneva
after a first, presumably unprovoked seizure. Our institu-
tion is the only hospital in the canton (province) of Geneva
(approx. 400,000 people) that offers continuous neurolog-
ical care on an emergency basis. Seizures related to with-
drawal in chronic drug or alcohol abusers or to metabolic
disorders or acute cerebral lesions (less than 7 days) were
cataloged as ‘‘provoked’’ and were excluded from the
present study. Sleep deprivation and acute alcohol con-
sumption were considered as predisposing factors to
unmask subclinical epilepsy disorders but not considered a
cause per se. The local ethics board approved the study.
Clinical protocols
SPC approach
The SPC consisted of an initial clinical evaluation by an
emergency physician who determined the key problem
upon admission and requested routine blood tests, elec-
trocardiogram (ECG), and CT. The emergency physician
determined the need for a specialized neurology consulta-
tion. All patients in the study remained in the ED for
observation for between 12 and 24 h. A routine EEG was
performed before ED discharge. Based on the patient’s
history, head-CT and EEG results, a diagnosis and safety
advice (driving, swimming, etc.) were formulated and
communicated to the patient. The patient was then advised
to make an appointment with his GP or with a neurologist
of his choice to ensure proper follow-up. A list of neurol-
ogists with expertise in epileptology, including those
available for in-house consultation, was given to the
patient. In the discharge report, MRI and/or long-term EEG
(LTM-EEG) were recommended whenever they were
deemed necessary for the diagnosis.
ECPC protocol
This protocol aimed to extend the SPC and to offer expert
epilepsy care already in the ED. The patient’s history was
taken by a board certified epileptologist in the ED and
included careful research on the presence of previous sei-
zures or relevant co-morbidities. Depending on the patient’s
initial evaluation and history, additional tests were arran-
ged. In both the SPC and ECPC groups, a routine EEG was
requested before ED discharge. If CT and routine EEG were
not informative, MRI and LTM-EEG were scheduled
within 72 h. If standard EEG findings strongly supported
genetic generalized epilepsy (IGE), no imaging was per-
formed. A preliminary diagnosis and socio-professional
recommendations (including driving) were communicated.
One to three weeks after the initial event, a follow-up
was scheduled in the epilepsy outpatient clinic to com-
municate the final or most likely diagnosis, the prognosis
and the long-term medical and socio-professional conse-
quences. Emergency measures and details about driving
limitations were also raised. Whenever a non-epileptic
event was suspected, the patient was referred to the
appropriate specialist. Finally, a three-month consultation
was arranged to assess diagnostic evolution and treatment
issues. Between 1 and 2 years after the ED admission, we
enquired all the patients (1-year follow-up).
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Study design
A randomized approach to allocate patients to SPC and ECPC
was not possible given the number of intervening physicians
and departments involved (Neurology, ED, Radiology). We,
therefore, decided upon a two-tiered approach. Patients
admitted between April 1, 2011 and March 31, 2012 were
included in the SPC group; the SPC protocol has been con-
sidered the ‘‘established approach’’ in our institution formany
years. Patients admitted between April 1, 2012 and June 6,
2013 were included in the ECPC group.
EEG
Standard EEGs were recorded for 20 min in agreement
with standard recommendations [12, 24], including photic
stimulation and hyperventilation. Regarding photic stimu-
lation protocol, stimulation was applied during eyes closed
and eyes open. The frequency of stimulation increased
from 2 to 60 Hz. During hyperventilation, the patient his
asked to breathe deeply during 3 min. Normal routine EEG
or non-epileptogenic abnormalities (for instance, focal
slowing) were considered inconclusive, requiring further
LTM-EEG investigation. LTM-EEG required two addi-
tional electrodes over both anterior–temporal regions [18]
(for a total of 21 electrodes). The LTM-EEG started in the
afternoon up to the next morning for a length of around
18 h. The early awakening period was helpful in identi-
fying genetic generalized epilepsy syndromes [20]. The
induction of a generalized spike-wave pattern by photic
stimulation or hyperventilation, with or without a history of
absence seizures or myoclonic jerks, was considered evi-
dence of genetic generalized epilepsy syndrome. Patients
were video-recorded during both routine and LTM-EEG.
Imaging
Brain CT scans were conducted using a 3 mm slice thickness.
Images were acquired before and after contrast administra-
tion. 3T MRI with a 32-channel brain coil was used to obtain
high-resolution images. We used a protocol that also enabled
us to search for cortical malformations: coronal fast spin echo
T2 (FSET2: repetition time (TR) 7520 ms; echo time (TE)
114 ms; voxel size 0.5 9 0.4 9 slice thickness 3 mm). This
protocol included perpendicular positioning of the slices
relative to the hippocampus, 3D Fluid inversion recovery
(FLAIR: TR 5000 ms; TE 419 ms; inversion time (TI)
1800 ms; isotropic voxel size 0.9 9 0.9 9 0.9 mm), diffu-
sion tensor imaging (DTI: TR 8000 ms; TE 84 ms, with 30
gradient directions), and arterial spin labeling (ASL: TR
4000 ms; TE 12 ms, voxel size 3.4 9 3.4 9 3.4 mm with a
slice thickness of 4 mm). If a tumor was suspected, spin echo
(SE) T1 imaging was conducted before and after contrast
administration, and a 3DT1 imagewas acquired after contrast
administration. If hemorrhagic lesions were visible on CT,
vascular sequences were added. In cases in which autoim-
mune disorders were a suspected cause of seizure, we added
contrast and additional axial gradient echo T2 (GET2: TE
20 ms, TR 832 ms; slice thickness 4 mm) or susceptibility
weighted imaging (SWI: TE 20 ms; TR 27 ms; 15 flip
angle).
Diagnosis
The final diagnosis was established as ‘‘epileptic seizure’’
or ‘‘cardiovascular’’, ‘‘psychogenic’’, ‘‘other’’, or ‘‘un-
known’’ event (undetermined despite the work-up and
expert patient history taking).
An epileptic origin was not based on patient or witness
history alone and was retained only if evidence arose from
CT, MRI or standard or LTM-EEG. A cardiovascular event
diagnosis was given if the patient’s history, ECG or blood
tests were evocative. As suggested in the literature [3], the
diagnosis of both orthostatic hypotension and vasovagal
syncope relied mainly on the patient’s symptoms and the
event history. The diagnosis of psychogenic non-epileptic
seizure was based on seizure semiology and its context,
negative findings in all other exams and the obligatory
presence of a traumatizing event and/or current or past
psychiatric disorders. Other final diagnoses were based on
the results of further investigations, which were scheduled if
deemed necessary. In cases of probable seizure or an unclear
diagnosis, we retained a diagnosis of ‘‘unknown’’ event.
Cost analysis
Cost analysis was performed using the medical catalog
utilized in Switzerland (TARMED). We compared hospital
costs between both groups as well as the costs associated
with additional exams such as brain imaging and elec-
troencephalography studies. All cost results were reported
in US$, using a rounded conversion exchange rate of
US$1 = 1 Swiss franc (August 20, 2015).
Statistics
When we conducted a power analysis, we took into con-
sideration a type I error rate of 5 % (two-sided) and our
observation that approximately 30 % of all patients do not
complete follow-up consultations once they are discharged
from the ED. We therefore calculated that at least 70
patients in each arm were necessary to determine if ECPC
leads to a higher attendance rate at epileptology consulta-
tions. Group comparisons were performed using Fisher’s
exact test or the Chi-square test when relative frequencies
were considered using SPSS software version 21.
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Results
Patients
A total of 183 patients were included in the study, 113 in
the ECPC group and 70 in the SPC group. Patients’ char-
acteristics are detailed in Table 1.
EEG
Both groups underwent standard EEG within 72 h of
admission. Among the patients, 73 % underwent the exam
within the first 24 h in the ECPC group vs 66 % in the SPC
group (p = 0.17). Two patients in each group did not
receive a standard EEG. An epileptogenic focus was
identified in 13/111 (12 %) of the patients in the ECPC
group and in 13/68 (19 %) of the patients in the SPC group
(p = 0.17). Standard EEG was normal in 66 (58 %)
patients of the ECPC group and 39 (56 %) patients of the
SPC group.
LTM-EEG was performed in 33/66 (50 %) of the
patients in the ECPC group and in 2/39 (5 %) of the
patients in the SPC group due to an unrevealing standard
EEG (p\ 0.0001). In the ECPC group, ten additional cases
with epileptogenic anomalies or instances of focal slowing
were found, indicating a LTM-EEG yield of 30 % (10/33).
LTM-EEG revealed subclinical seizure activity in three
patients in the ECPC group but in none of the patients in
the SPC group (an example is shown in Fig. 1, Table 2).
Brain imaging
The number of abnormal CT findings did not differ
between the groups (31/97 (32 %) in the ECPC group vs
Table 1 Characteristics of the
patients the ECPC (early
comprehensive patient care) and
SPC (standard patient care)
groups
ECPC (%) SPC (%) p value
N 113 70
Age (years) 43.6 ± 19.1 years 50.1 ± 22.5 years 0.053
Sex
Female 51 (45) 26 (37) 0.29
Male 62 (55) 44 (63)
Personal history
Neurological 37 (33) 26 (37) 0.77
Cardiovascular 6 (5) 5 (7)
Psychiatric 11 (10) 8 (11)
Other* 6 (5) 5 (7)
None 53 (47) 26 (37)
Previous seizures
None 79 (70) 61 (87) 0.047
1 11 (10) 2 (3)
[1 17 (15) 4 (6)
Unknown 6 (5) 3 (4)
Timing
Wakefulness 98 (87) 56 (80) 0.0001
Sleep 14 (12) 3 (4)
Unknown 1 (0.9) 11 (16)
Semiology
Focal 23 (20) 21 (30) 0.26
Focal 2nd generalized 29 (26) 13 (19)
Generalized 61 (54) 36 (51)
Precipitating factors
Sleep deprivation 23 (20) 8 (11) 0.61
Drugs 2 (18) 2 (3)
Withdrawal 7 (62) 5 (7)
Fever/infection 2 (18) 1 (1)
None 79 (70) 54 (77)
* All other medical history, e.g., neoplasms, surgical interventions, etc
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27/58 (47 %) in the SPC group; p = 0.07). When CT was
inconclusive, MRI was performed in 56/66 (85 %) of the
patients in the ECPC group and in 16/31 (52 %) of the
patients in the SPC group (p = 0.0005). The mean delay to
complete the MRI was 12 days in the ECPC group and
32 days in the SPC group (p = 0.001). When MRI was
performed, no difference in the number of abnormal find-
ings was observed. MRI was abnormal in 17/56 (30 %) of
the patients with normal CT in the ECPC group; among
these patients, 11 showed epileptogenic lesions. These
findings correspond to an additional yield of 20 % (11/56).
MRI identified all lesions observed on CT scan (an
example is shown in Fig. 2). The abnormal MRI findings
are detailed in Table 3.
Follow-up
A follow-up visit was conducted in 95/113 (84 %) of the
patients in the ECPC group compared to 31/70 (44 %) of
the patients in the SPC group (p = 0.0001). The median
time to the appointment was 15 days (interquartile ratio
(IQR) 10–28) in the ECPC group and 20 days in the SPC
group (IQR 6–43). Among the patients diagnosed with
epilepsy, those in both groups were equally likely to benefit
from antiepileptic drugs (AEDs), which were administered
in 42/51 (82 %) of the patients in the ECPC group and
20/24 (83 %) of the patients in the SPC group (p = 0.91).
The three-month consultation occurred in 63/113 (56 %)
of the patients in the ECPC group (with a median delay of
99 days (IQR 69–119) compared to in 18/70 (26 %) of the
patients in the SPC group (with a median delay of 129 days
(IQR 96–179); p\ 0.001). Among those being treated with
AEDs, seizure relapses were observed in 8/44 (18 %) of
the patients of the ECPC group and in 1/20 (5 %) of the
patients in the SPC group (p = 0.16).
At 1 year, 43/113 (38 %) of the patients in the ECPC
group were followed by a neurologist vs 14/70 (20 %) of
the patients in the SPC group (p = 0.01). Considering only
patients with epilepsy, 34/57 (60 %) in the ECPC group
were followed by an neurologist vs 7/24 (29 %) in the SPC
group (p = 0.01). In the ECPC group, 20 (18 %) patients
were re-admitted to the ED after a new epileptic seizure
compared to 7 (10 %) patients in the SPC group
(p = 0.15). The mean time until seizure relapse was
437 days in the ECPC group vs 186 days in the SPC group
(p = 0.008).
Fig. 1 A 21-year-old patient who experienced a presumably first
seizure in the morning in the shower. Review of the patient’s history
by an epileptologist, and not a general neurologist, identified that this
event was already the 4th seizure, all of which occurred in the
morning. Standard EEG was normal (a), but LTM-EEG showed
bursts of generalized polyspike waves, particularly in the morning (b).
Genetic generalized epilepsy (‘‘grand mal on awakening’’) was
diagnosed, and lamotrigine successfully introduced
Table 2 Standard and long-term EEG performed in both groups
ECPC SPC p value
Standard EEG
Abnormal findings 45/111 29/68 0.78
Ictal 3 3
Focal spikes 5 3
Gen. spikes 6 7
Focal slowing 23 14
Gen. slowing 8 2
LTM-EEG
Abnormal findings* 21/50 2/7 0.49
Ictal 3 0
Focal spikes 8 0
Gen. spikes 7 1
Focal slowing 2 1
Gen. slowing 1 0
* This table presents all pathological finding in the patient’s EEG
(e.g., focal spikes were often associated with focal slowing but were
categorized as ‘‘focal spikes’’ only). The subcategories of abnormal
EEG finding were distributed similarly in both groups: standard EEG
p = 0.55, LTM-EEG p = 0.46
2390 J Neurol (2016) 263:2386–2394
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Diagnosis
At 3 months, a final diagnosis was obtained in 75/113 (66 %)
of the patients in the ECPC group compared to 30/70 (43 %)
of the patients in the SPC group (p = 0.002). Epileptic events
were diagnosed in 57/113 (50 %) of the patients in the ECPC
group vs 24/70 (34 %) of the patients in the SPC group
(p = 0.03). A diagnosis of unknown event was significantly
less common in the ECPC group than in the SPC group (38/
113 (34 %) in the ECPC group vs 40/70 (57 %) in the SPC
group; p = 0.002). All results are detailed in Table 4.
At 1 year, 21/113 (19 %) of the patients in the ECPC
group were diagnosed with an unknown event vs 22/70
(31 %) of the patients in the SPC group (p = 0.046)
(Table 5). In both groups, more patients received a final
diagnosis at 1 year (ECPC: p = 0.036, SPC: p = 0.009)
because other events enabled correct categorization; how-
ever, this was more pronounced for the SPC group. Since
diagnoses were based on positive investigations only, no
diagnosis changed during follow-up for the already diag-
nosed patients. On the other hand, a final diagnosis was
established for many patients in both groups in
Fig. 2 A 16-year-old patient
with a first generalized tonic–
clonic seizure. Standard EEG
and CT were unrevealing (a),
but MRI showed
polymicrogyria in the R
opercular region (b; the right
side of the brain is to the left
side from the perspective of the
viewer; lesion inside the red
circle). Focal epilepsy was
diagnosed, requiring close
monitoring of seizure
recurrence, including focal
seizures with a more subtle
semiology
Table 3 Details of MRI abnormalities in both groups
ECPC (%) N = 86 SPC (%) N = 35 p value
Abnormal findings 38 (44) 16 (46) 0.879
Vascular 7 (8) 5 (14)
Tumoral 15 (17) 8 (23)
Metastasis 3 2
Meningioma 4 0
Glioma 1 2
Vascular tumor (cavernoma, hemangioblastoma) 5 2
Cyst 2 2
Trauma 2 (2) 0
Malformation 9 (10) 1 (3)
Hippocampal malformation 4 1
Hippocampal asymmetry/sclerosis 3 0
Temporal cortical dysplasia 2 0
Other 5 (7) 2 (6)
Global or focal atrophy* 2 1
Increased white matter lesions with proximity to the cortex 2 1
Hippocampal hyperintensity 1 0
This table summarizes abnormal MRI findings in 86 patients from the ECPC group and in 35 patients from the SPC group. The pathology
categories were similar in both patient groups (p = 0.43)
* Mammillary body or temporal atrophy
J Neurol (2016) 263:2386–2394 2391
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the ‘‘unknown’’ category after 1 year of evaluation. This is
true for 14 patients in the ECPC and SPC group each, with
the diagnostic events being mainly recurrent fits that
allowed the identification of the underlying pattern or
subsequent positive investigations (e.g., another EEG with
postictal abnormalities). Most patients moved from a
diagnosis of ‘‘unknown’’ to ‘‘epilepsy’’ (Table 5).
Cost analysis
Both the costs and resources used indicated a significant
difference between the patient cohorts, in line with the
number of complementary diagnostic tests performed. In
particular, sleep EEG and cranial MRI were more often
implemented in the ECPC group than in the SPC group; in
contrast, cranial CT was slightly more commonly carried
out in the SPC group than in the ECPC group (89 vs 83 %).
The ECPC-related procedures were associated with higher
costs from pre-hospitalization to outpatient clinic care, i.e.,
$1431 vs $1035 as direct medical costs and $2573 vs $2065
as the global medical management cost. Conversely, no
difference was found in the cost of the total number of
laboratory tests ($383 vs $381) or in ED costs.
Discussion
This study demonstrates the superiority of early compre-
hensive care by epilepsy experts over the conventional
approach in terms of patient follow-up, final diagnosis and
seizure recurrence. When the medical history was obtained
by epileptologists, critical elements for prognosis were
identified compared to when the history was obtained by
other professionals in the ED setting. Moreover, when the
work-up was organized in the emergency room, within
hours after the seizure, adherence to follow-up increased
significantly, even 1 year later.
When the follow-up was organized by epilepsy experts,
the patients more often and more quickly received MRI and
LTM-EEG, which, in turn, increased the diagnostic accu-
racy of the precipitating event. In fact, our study showed an
additional yield of 20 and 30 % for MRI and LTM-EEG,
respectively. This additional yield of LTM-EEG, including
sleep recording, is comparable to that found in previous
studies [15]. The presence of epileptogenic abnormalities
after a first seizure is reported in approximately 12–27 %
of cases using standard EEG [21] and in up to 58 % when
sleep EEG is obtained [11, 14, 23, 25]. The yield of stan-
dard EEG is augmented if it is obtained within the first
24 h, e.g., the detection of epileptiform abnormalities
increased from 34 to 51 % [11]. In our study, 35 % of
patients presented epileptiform abnormalities in their early
EEG; these results are similar to those of Prawidal et al.
[19] but lower than those reported in the study of King
et al. [11], likely because our population included only
adults whereas their study included both adults and chil-
dren. Notably, three patients in the ECPC group but none in
the SPC group showed ictal activity on LTM-EEG, which
led to immediate treatment initiation and in-house
supervision.
Table 4 Distribution of
diagnoses in the ECPC
(N = 113) and SPC (N = 70)
groups at the 3-month follow-up
ECPC (%) N = 113 SPC (%) N = 70 p value
Epileptic seizures 57 (50) 24 (34) 0.02
IGE 10 (18) 5 (21)
Symptomatic 29 (53) 16 (64)
Cryptogenic 15 (26) 1 (4)
Not classified 3 (5) 2 (8) 0.15
Cardiovascular disease 14 (12) 3 (8) 0.07
Psychogenic 0 0 –
Other 4 (4) 3 (8) 0.54
Unknown 38 (34) 40 (57) 0.003
Table 5 Evolution of
diagnostic categorization
Epileptic seizure Non-epileptic seizure Unknown diagnosis p value
3 months 12 months 3 months 12 months 3 months 12 months
ECPC (N = 113) 57 (50) 71 (63) 18 (15) 21 (17) 38 (34) 21 (19) 0.036
SPC (N = 70) 24 (34) 38 (53) 6 (9) 10 (10) 40 (57) 22 (31) 0.009
Follow-up at 12 months enabled a decrease in the number of patients with a diagnosis of ‘‘unknown origin’’
in both the ECPC and SPC groups. Most often, the patients eventually received a diagnosis of ‘‘epilepsy’’.
While this was true for the patients in both groups, the evolution of diagnostic categorization was more
pronounced in the SPC patients due to the lower initial diagnostic precision
2392 J Neurol (2016) 263:2386–2394
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The superiority of MRI over CT is now established
knowledge, and this superiority also extends to the ED
setting [2, 9, 11]. In a recent study of 764 patients at a ‘‘first
seizure clinic’’, 23 % had an epileptogenic lesion on MRI
[9], similar to our study. These results suggest that directly
ordering an MRI could save time and money if local
resources allow rapid in-house MR imaging.
At 12 months, fewer patients in both the ECPC and SPC
groups continued to have a diagnosis of ‘‘unknown origin’’.
Most of the patients were diagnosed with ‘‘epilepsy’’.
Indeed, if MRI and initial EEGs are unrevealing, only the
recurrence of events of similar semiology and a subsequent
EEG with focal discharges enables a diagnosis of epilepsy.
However, if the patient received early comprehensive care,
more patients were correctly diagnosed initially. As a
result, long-term follow-up was less crucial for obtaining
the correct ‘‘epilepsy’’ diagnosis in the ECPC patients than
in the SPC patients.
The consequences of structured early follow-up were
evident even at the long-term follow-up. Compared to the
patients with epilepsy in the SPC group, those in the ECPC
group were significantly more likely to be followed by a
neurologist 1 year after the index event. The seizure
relapse rate did not differ between the two groups, indi-
cating that the type of initial ED care does not influence the
disease prognosis itself. However, we showed that the
delay between the first event and the next ED re-admission
was significantly longer in the ECPC group (437 and
186 days in the ECPC and SPC groups, respectively),
which suggests that these patients better understood their
condition (i.e., calling the epilepsy expert the next day
rather than returning to the ED) and the importance of
treatment compliance and lifestyle adjustments (i.e.,
avoiding precipitating factors) [5]. However, further stud-
ies are required to determine if this understanding trans-
lates into significant medical and socio-professional long-
term effects of ECPC.
Both systematic reviews and cost-of-illness (COI)
studies have reported a consistent pattern of markedly
higher costs associated with those with uncontrolled or
refractory epilepsy [1]. Our cost calculations were consis-
tent with previous COI studies, which estimated that over
1 year (prevalence based), the direct medical costs related
to epilepsy mainly involved the costs of return visits and
long-term therapy [17]. A total annual cost of €1698
($1919) per patient with active epilepsy treated in private
neurological offices was reported in Germany [17],
whereas the highest annual cost for this patient group was
found in the US, at up to $13,787 [8]. Because we are not
dealing with chronic epilepsy, the costs of the first seizure
work-up are lower. We calculated a difference of approx-
imately $500 in favor of SPC. However, our study high-
lighted that despite the higher upfront investigational cost
of ECPC, the patients in this group benefited from fewer
subsequent ED and hospital admissions. In the long run, a
reduction in admissions reduces health care needs and
limits resource consumption. We hypothesize that the
direct and indirect economic benefits will become even
more apparent beyond the first year due to targeted treat-
ment of conditions mimicking epilepsy (e.g., psychogenic
seizures), better drug adherence in patients with epilepsy,
earlier curative treatment (surgery), fewer truly
intractable patients and, consequently, fewer ED or hos-
pital admissions and less absenteeism at work.
The major limitation of this study is the lack of ran-
domization in assigning patients to SPC or ECPC: we felt
that randomization was not practically possible, given the
number of implicated teams. In our opinion, successive
cohorts in the same ED setting represent the best alter-
native. Moreover, this is a single-center study, which
should be confronted to a multicenter trial to confirm our
findings. Another limitation is related to the setting of the
study, which was conducted at a university hospital in a
country with a rather affluent health care system, which
allowed rapid in-house organization of more advanced
exams. While this type of care may appear difficult to put
into place in smaller hospitals, training of general neu-
rologists, rapid access to MRI, and overnight EEG could
also be achieved in non-university settings or in collab-
oration with university hospitals. The study’s setting
allowed us to determine the yield of comprehensive
patient care by epilepsy experts given that for both pro-
tocols, both admission and the initial work-up were
completed at the same center (ED). Finally, we did not
derive quality-of-life estimates, which could have pro-
vided a measure of additional patient-reported outcomes
and the benefits of ECPC compared to SPC which rep-
resents current ethical standard patient care.
Our data provide new and important information
regarding the clinical value of comprehensive patient
management after a first epileptic seizure, supporting an
early in-hospital approach that is carried out by epilepsy
experts. Based on our encouraging results, long-term
studies regarding the effects of standard or comprehensive
epilepsy care on drug compliance, seizure relapse, quality
of life and even mortality should be conducted.
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